Spirulina Market to Reach USD 2.98 Billion by 2032, Growing at a CAGR of 16.53% During 2026–2032
The Global Spirulina Market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.19 billion in 2026, further expanding to USD 2.98 billion by 2032, registering a CAGR of 16.53% during the forecast period. Market growth is being fueled by rising consumer demand for nutrient-dense natural ingredients, expanding adoption of plant-based nutrition, and increasing awareness regarding preventive healthcare. The growing incorporation of spirulina into dietary supplements, functional foods, beverages, and wellness products continues to strengthen its commercial relevance across global markets.
In terms of segmentation, arthrospira platensis dominates the market, accounting for approximately 85% share in 2026. The segment’s leadership is supported by its superior nutritional composition, high protein concentration, scalability for commercial cultivation, and widespread utilization across food, nutraceutical, and natural colorant applications. By application, Dietary Supplements/Nutraceuticals account for approximately 42% of market revenue, driven by increasing consumer focus on immunity, healthy aging, preventive healthcare, and plant-based wellness solutions. Strong dietary supplement adoption rates continue to reinforce demand for spirulina-based products worldwide.
Regionally, Asia-Pacific holds the largest share of the spirulina market, accounting for approximately 39% of total revenue in 2026. The region’s dominance is supported by established microalgae cultivation capabilities, expanding nutraceutical industries, and growing consumer awareness regarding health and wellness. Countries such as China, India, Japan, and South Korea continue to invest in biotechnology development and sustainable biological production systems, strengthening regional production capacity. Additionally, rising demand for dietary supplements, natural food colorants, and alternative proteins continues to reinforce Asia-Pacific’s leadership position throughout the forecast period, as stated in “Spirulina Market Analysis 2026”.
Spirulina Market Highlights
- The Global Spirulina Market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.19 billion in 2026, further expanding to USD 2.98 billion by 2032.
- The market is expected to register a CAGR of 16.53% during 2026–2032, supported by growing demand for sustainable protein sources, plant-based nutrition, and preventive healthcare products.
- Asia-Pacific holds the leading position with approximately 39% market share in 2026, driven by strong microalgae cultivation capabilities, expanding nutraceutical industries, and increasing biotechnology investments.
- By Type, Arthrospira Platensis accounts for approximately 85% share in 2026, supported by its superior nutritional profile, high phycocyanin content, and suitability for large-scale commercial cultivation.
- By Application, Dietary Supplements/Nutraceuticals dominate with approximately 42% share in 2026, driven by growing consumer focus on immunity support, wellness, and plant-based nutrition.
- The market remains highly fragmented, with DIC Corporation, Earthrise Nutritionals LLC, Cyanotech Corporation, E.I.D. Parry Limited, and Fuqing King Dnarmsa Spirulina Co., Ltd. collectively accounting for approximately 19% of total market share.
Spirulina Market Segmentation
By Type
- Arthrospira Platensis
- Arthrospira Maxima
By Form
- Powder
- Tablets
- Capsules
- Flakes
- Liquid
- Extracts (Phycocyanin)
By Nature
- Organic Spirulina
- Conventional Spirulina
By Application
- Dietary Supplements / Nutraceuticals
- Food & Beverages
- Pharmaceuticals
- Cosmetics & Personal Care
- Animal Feed & Aquaculture
- Agriculture & Fertilizers
- Others
By Distribution Channel
- Online Retail
- Supermarkets & Hypermarkets
- Pharmacies & Drug Stores
- Others
By Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Players in the Spirulina Market
- DIC Corporation
- Earthrise Nutritionals, LLC
- Cyanotech Corporation
- E.I.D. Parry Limited
- Fuqing King Dnarmsa Spirulina Co., Ltd.
- Dongtai City Spirulina Bio-Engineering Co., Ltd.
- Inner Mongolia Rejuve Biotech Co., Ltd.
- Australian Spirulina (TAAU Australia Pty Ltd)
- Far East Microalgae Industries Co., Ltd.
- Fraken Biochem Co., Ltd.
- Parry Nutraceuticals
- Algalif Iceland ehf.
- Tianjin Norland Biotech Co., Ltd.
- Yunnan Green A Biological Project Co., Ltd.
- Algene Biotech
We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:
Buy NowNeed Assistance?
WRITE AN EMAIL
sales@marknteladvisors.comCustomization Offered
100% Safe & Secure
Strongest encryption on the website to make your purchase safe and secure